High Net Worth Advisory Group LLC Alnylam Pharmaceuticals, Inc. Transaction History
High Net Worth Advisory Group LLC
- $388 Million
- Q3 2025
A detailed history of High Net Worth Advisory Group LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 1,500 shares of ALNY stock, worth $674,340. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$674,340
Previous $489,000
39.88%
% of portfolio
0.18%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
806Shares Held
116MCall Options Held
584KPut Options Held
648K-
Capital World Investors Los Angeles, CA16.8MShares$7.55 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$5.98 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.23 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$1.92 Billion0.88% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...